Aptorum Group Limited (NASDAQ:APM) Short Interest Update

Aptorum Group Limited (NASDAQ:APM) was the target of a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 4,200 shares, a decline of 30.0% from the August 31st total of 6,000 shares. Based on an average daily volume of 13,700 shares, the short-interest ratio is currently 0.3 days. Approximately 0.2% of the shares of the company are sold short.

Institutional Investors Weigh In On Aptorum Group

An institutional investor recently bought a new position in Aptorum Group stock. Murchinson Ltd. purchased a new stake in shares of Aptorum Group Limited (NASDAQ:APM) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 14,000 shares of the company’s stock, valued at approximately $133,000. Murchinson Ltd. owned 0.27% of Aptorum Group as of its most recent SEC filing. Institutional investors and hedge funds own 3.80% of the company’s stock.

Aptorum Group Stock Performance

APM traded down $0.02 during midday trading on Friday, reaching $1.85. The company had a trading volume of 15,262 shares, compared to its average volume of 830,728. Aptorum Group has a 1 year low of $1.35 and a 1 year high of $17.49. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18 and a current ratio of 1.18. The business has a 50-day moving average of $2.92 and a two-hundred day moving average of $4.73.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.